000 | 03568cam a22004577a 4500 | ||
---|---|---|---|
999 |
_c6205 _d6205 |
||
001 | 13735564 | ||
003 | KENaKMTC | ||
005 | 20180201105246.0 | ||
007 | ta | ||
008 | 040407s2003 sz a b i001 0 eng d | ||
010 | _a 2004456821 | ||
020 | _a9241546018 | ||
035 | _a(OCoLC)ocm54898555 | ||
040 |
_aGZN _cGZN _dCOU _dVAM _dOCLCQ _dDLC |
||
042 | _alccopycat | ||
050 | 0 | 0 | _aRA 410.5. E4 2003 |
082 | 0 | 0 |
_a362.1 _222 |
090 |
_aRA410.5 _b.M35 2003 |
||
245 | 0 | 0 |
_aMaking choices in health : _bWHO guide to cost-effectiveness analysis / _cedited by T. Tan-Torres Edejer ... [et al.]. |
246 | 3 | 0 | _aWHO guide to cost-effectiveness analysis |
260 |
_aGeneva : _bWorld Health Organization, _cc2003. |
||
300 |
_axiii, 312, [8] p. : _bill. ; _c24 cm. + _e1 CD card (2 1/4 x 3 1/4 in.) |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aPart One: METHODS FOR GENERALIZED COST-EFFECTIVENESS -- Ch. 1. What is generalized cost-effectiveness analysis? -- Ch. 2. Undertaking a study using GCEA -- Ch. 3. Estimating costs -- Ch. 4. Estimating health effects -- Ch. 5. Discounting -- Ch. 6. Uncertainty in cost-effectiveness analysis -- Ch. 7. Policy uses of generalized CEA -- Ch. 8. Reporting CEA results -- Ch. 9. Summary of recommendations -- Annex A. WHO-CHOICE activities on generalized cost-effectiveness analysis -- Annex B. Draft list of intervention clusters for evaluation by WHO-CHOICE -- Annex C. An illustration of the types of costs included in a selection of intervention activities at central levels -- Annex D. Interpreting international dollars -- Annex E. DALYs to measure burden of dollars -- Annex F. Measuring intervention benefit at the population level -- Annex G. Epidemiological subregions as applied in WHO generalized CEA -- Part Two: BACKGROUND PAPERS AND APPLICATIONS -- Ch. 1. Development of WHO guidelines on generalized cost-effectiveness analysis -- Ch. 2. PopMod: a longitudinal population model with two interacting disease states -- Ch. 3. Programme costs in the economic evaluation of health interventions -- Ch. 4. Econometric estimation of country-specific hospital costs -- Ch. 5. Stochastic league tables: communicating cost-effectiveness results to decision-makers -- Ch. 6. Uncertainty in cost-effectiveness analysis: probabilistic uncertainty analysis and stochastic league tables -- Ch. 7. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk -- Ch. 8. Generalized cost-effectiveness analysis: an aid to decision making in health -- Ch. 9. Ethical issues in the use of cost effectiveness analysis for the prioritization of health care resources. | |
650 | 0 |
_aMedical care _xCost effectiveness. |
|
650 | 0 |
_aMedical care, Cost of _xEvaluation. |
|
650 | 0 | _aOutcome assessment (Medical care) | |
650 | 1 | 2 |
_aCost-Benefit Analysis _xmethods. |
650 | 1 | 2 |
_aHealth Planning _xmethods. |
650 | 1 | 2 |
_aHealth Care Rationing _xeconomics. |
650 | 1 | 2 |
_aHealth Priorities _xeconomics. |
650 | 2 | 2 | _aPolicy Making. |
650 | 2 | 2 | _aDecision Support Techniques. |
650 | 2 | 2 | _aModels, Econometric. |
650 | 2 | 2 | _aHealth Care Costs. |
655 | 7 |
_aGuideline. _2mesh |
|
700 | 1 | _aEdejer, Tessa Tan-Torres. | |
710 | 2 | _aWorld Health Organization. | |
906 |
_a7 _bcbc _ccopycat _d3 _encip _f20 _gy-gencatlg |
||
942 |
_2lcc _cBK _xJAO |